BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25563490)

  • 21. Histological and immunohistochemical studies on primary intracranial canine histiocytic sarcomas.
    Thongtharb A; Uchida K; Chambers JK; Kagawa Y; Nakayama H
    J Vet Med Sci; 2016 May; 78(4):593-9. PubMed ID: 26668164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indolent cutaneous T-cell lymphoma presenting as cutaneous lymphocytosis in dogs.
    Affolter VK; Gross TL; Moore PF
    Vet Dermatol; 2009 Oct; 20(5-6):577-85. PubMed ID: 20178497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canine inflamed nonepitheliotropic cutaneous T-cell lymphoma: a diagnostic conundrum.
    Moore PF; Affolter VK; Keller SM
    Vet Dermatol; 2013 Feb; 24(1):204-11.e44-5. PubMed ID: 23331699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant fibrous histiocytoma and malignant histiocytosis in the dog--convergent or divergent phenotypic differentiation?
    Kerlin RL; Hendrick MJ
    Vet Pathol; 1996 Nov; 33(6):713-6. PubMed ID: 8952034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of cytoplasmic lysozyme immunoreactivity as a histiocytic marker in canine histiocytic disorders.
    Moore PF
    Vet Pathol; 1986 Nov; 23(6):757-62. PubMed ID: 3027941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological and immunohistochemical features of subdural histiocytic sarcomas in 15 dogs.
    Ide T; Uchida K; Kagawa Y; Suzuki K; Nakayama H
    J Vet Diagn Invest; 2011 Jan; 23(1):127-32. PubMed ID: 21217043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytologic identification of erythrophagocytic neoplasms in dogs.
    Barger AM; Skowronski MC; MacNeill AL
    Vet Clin Pathol; 2012 Dec; 41(4):587-9. PubMed ID: 23016693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant fibrous histiocytomas in dogs and cats: an immunohistochemical study.
    Thoolen RJ; Vos JH; van der Linde-Sipman JS; de Weger RA; van Unnik JA; Misdorp W; van Dijk JE
    Res Vet Sci; 1992 Sep; 53(2):198-204. PubMed ID: 1332152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple cutaneous histiocytomas treated with lomustine in a dog.
    Maina E; Colombo S; Stefanello D
    Vet Dermatol; 2014 Dec; 25(6):559-62, e98-9. PubMed ID: 24963782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The regression of a canine Langerhans cell tumour is associated with increased expression of IL-2, TNF-alpha, IFN-gamma and iNOS mRNA.
    Kaim U; Moritz A; Failing K; Baumgärtner W
    Immunology; 2006 Aug; 118(4):472-82. PubMed ID: 16764690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression of vimentin, E-cadherin, and CD45 in natural cases of canine cutaneous round tumors.
    Oda SS; Tawfik MF; Othman SI; Rudayni HA; Allam AA; Khafaga AF
    Braz J Biol; 2024; 84():e278769. PubMed ID: 38422292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical prognostic factors in canine histiocytic sarcoma.
    Dervisis NG; Kiupel M; Qin Q; Cesario L
    Vet Comp Oncol; 2017 Dec; 15(4):1171-1180. PubMed ID: 27334037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spindle cell cutaneous epitheliotropic T-cell lymphoma in an American Bulldog.
    Carpenter A; Aeschlimann K; Kuroki K
    J Comp Pathol; 2024 Apr; 210():1-4. PubMed ID: 38417247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneously regressive canine cutaneous histiocytoma: a counterpart of human regressing atypical histiocytosis?
    Yang TJ
    Anticancer Res; 1987; 7(4B):811-2. PubMed ID: 2823685
    [No Abstract]   [Full Text] [Related]  

  • 35. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
    Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
    BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease of E-cadherin expression in canine cutaneous histiocytoma appears to be related to its spontaneous regression.
    Pires I; Queiroga FL; Alves A; Silva F; Lopes C
    Anticancer Res; 2009 Jul; 29(7):2713-7. PubMed ID: 19596951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical cytologic presentation of a histiocytic sarcoma in a Cavalier King Charles Spaniel dog.
    Clarke LL; Kelly LS; Garner B; Brown CA
    J Vet Diagn Invest; 2017 Jul; 29(4):541-543. PubMed ID: 28381106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canine histiocytic neoplasia: an overview.
    Fulmer AK; Mauldin GE
    Can Vet J; 2007 Oct; 48(10):1041-3, 1046-50. PubMed ID: 17987966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifocal cutaneous histiocytic sarcoma in a young dog and review of histiocytic cell immunophenotyping.
    Mastrorilli C; Spangler EA; Christopherson PW; Aubry OA; Newton JC; Smith AN; Kennis RA; Weismann JL; Moore PF
    Vet Clin Pathol; 2012 Sep; 41(3):412-8. PubMed ID: 22747712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotypic and ultrastructural evidence of the langerhans cell origin of the canine cutaneous histiocytoma.
    Marchal T; Dezutter-Dambuyant C; Fournel C; Magnol JP; Schmitt D
    Acta Anat (Basel); 1995; 153(3):189-202. PubMed ID: 8984828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.